🇺🇸
United States · US · US:67457-594_8de301f7-88ad-41d7-9ec3-884cab56f943
Arixtra
In shortageOrange BookUNIISPLATC B01AX05
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerMylan Institutional LLC
CountryUS (United States)
ATC codeB01AX05
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc11674575940610 SYRINGE, GLASS in 1 CARTON (67457-594-06) / .6 mL in 1 SYRINGE, GLASS (67457-594-00)
Annotations
UNII (FDA Substance ID)
X0Q6N9USOZ
FONDAPARINUX SODIUM
RxCUI 322154
Orange Book
N021345
APAPAPAP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Fondaparinux Sodium Injection
Raw payload (JSON)
{
"unii": {
"unii": "X0Q6N9USOZ",
"rxcui": "322154",
"inchikey": "XEKSTYNIJLDDAZ-JASSWCPGSA-D",
"display_name": "FONDAPARINUX SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"d3b30c68-cf45-4b46-8ba6-72090f7ba01a": {
"match": "brand_token",
"title": "ARIXTRA (FONDAPARINUX SODIUM) INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC]",
"spl_version": "13",
"published_date": "2025-02-03"
}
},
"productid": "67457-594_8de301f7-88ad-41d7-9ec3-884cab56f943",
"productndc": "67457-594",
"dosage_form": "INJECTION, SOLUTION",
"orange_book": {
"appl_no": "021345",
"products": [
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "2.5MG/0.5ML (2.5MG/0.5ML)",
"product_no": "001",
"approval_date": "Dec 7, 2001"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "5MG/0.4ML (5MG/0.4ML)",
"product_no": "002",
"approval_date": "May 28, 2004"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "7.5MG/0.6ML (7.5MG/0.6ML)",
"product_no": "003",
"approval_date": "May 28, 2004"
},
{
"rs": true,
"rld": true,
"te_code": "AP",
"strength": "10MG/0.8ML (10MG/0.8ML)",
"product_no": "004",
"approval_date": "May 28, 2004"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FONDAPARINUX SODIUM",
"shortage_reason": "Fondaparinux Sodium Injection",
"shortage_status": "current",
"proprietary_name": "Arixtra",
"active_ingred_unit": "mg/.6mL",
"application_number": "NDA021345",
"marketing_category": "NDA",
"nonproprietary_name": "fondaparinux sodium",
"start_marketing_date": "20140519",
"active_numerator_strength": "7.5"
}Related drugs
Other records sharing ATC code B01AX05.
Access this data programmatically
Query Arixtra and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.